Christopher Martell is a director of Candel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 14,240 | 17.37 k | 14,240 |
9 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 1.92 | 23,950 | 45.98 k | 152,000 |
8 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 1.68 | 3,050 | 5.12 k | 128,050 |